# FDA Inspection 1268222 - Zhejiang Chempacific Corporation - April 04, 2025

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-chempacific-corporation/5b51eea8-c619-4fb4-9076-6d2f5c510498
Source feed: FDA_Inspections

> FDA Inspection 1268222 for Zhejiang Chempacific Corporation on April 04, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1268222
- Company Name: Zhejiang Chempacific Corporation
- Inspection Date: 2025-04-04
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1268222 - 2025-04-04](https://www.keypedia.com/records/fda_inspections/zhejiang-chempacific-corporation/c08e1ac6-317f-4265-be3d-a9c1e7be2bf2)
- [FDA Inspection 1050336 - 2018-03-23](https://www.keypedia.com/records/fda_inspections/zhejiang-chempacific-corporation/38852223-11ec-436f-a575-a301a1e77434)
- [FDA Inspection 896936 - 2014-09-04](https://www.keypedia.com/records/fda_inspections/zhejiang-chempacific-corporation/639eec67-1766-445d-bdef-35477828d6a8)
- [FDA Inspection 728751 - 2011-05-06](https://www.keypedia.com/records/fda_inspections/zhejiang-chempacific-corporation/6883787f-003c-4590-b801-521c4fec9066)

Company: https://www.keypedia.com/companies/zhejiang-chempacific-corporation/d7e48883-0d85-4d70-a1be-e96379589a1f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c